Antares' testosterone injection found successful in late-stage study

February 25, 2015 3:00 PM

5 0

(Reuters) - Antares Pharma Inc said its once-weekly testosterone injection met the main goal in an ongoing late-stage study in testosterone-deficient adult males.

The U.S. Food and Drug Administration asked Antares last month for additional safety data on the drug, to be sold as QuickShot Testosterone, after a patient developed hives in a separate mid-stage trial.

Also read: RBS Fails Toughest-Ever BOE Stress Test, Boosts Capital Plan

Read more

To category page

Loading...